Atlas Trials

Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women

Clinical trial NCT02357602 · COMPLETED

Trial details

NCT number
NCT02357602
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2015-03-01
Primary completion
2015-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.